[Retracted] Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma

Figure 3

Construction of an lncRNA signature for glioma. (a) LASSO regression analysis on these 20 lncRNAs. (b) Figure 3(b) depicts the correlation between the lncRNAs expression and the risk score. (c) Kaplan–Meier analysis showed high-risk patients have a shorter OS than low-risk patients. (d) We then performed time-dependent ROC curve analysis to assess the ability of the PRLnc signature in predicting the OS of glioma patients.

(a)

(b)

(c)

(d)